NM_000295.5(SERPINA1):c.922G>T (p.Ala308Ser) AND not specified

Germline classification:: Benign/Likely benign (2 submissions)
Last evaluated:: Jun 2, 2016
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000366637.10

Allele description [Variation Report for NM_000295.5(SERPINA1):c.922G>T (p.Ala308Ser)]

NM_000295.5(SERPINA1):c.922G>T (p.Ala308Ser)

Gene:

SERPINA1:serpin family A member 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

14q32.13

Genomic location:

Preferred name:

NM_000295.5(SERPINA1):c.922G>T (p.Ala308Ser)

HGVS:

NC_000014.9:g.94379607C>A
NG_008290.1:g.16086G>T
NM_000295.5:c.922G>TMANE SELECT
NM_001002235.3:c.922G>T
NM_001002236.3:c.922G>T
NM_001127700.2:c.922G>T
NM_001127701.2:c.922G>T
NM_001127702.2:c.922G>T
NM_001127703.2:c.922G>T
NM_001127704.2:c.922G>T
NM_001127705.2:c.922G>T
NM_001127706.2:c.922G>T
NM_001127707.2:c.922G>T
NP_000286.3:p.Ala308Ser
NP_001002235.1:p.Ala308Ser
NP_001002236.1:p.Ala308Ser
NP_001121172.1:p.Ala308Ser
NP_001121173.1:p.Ala308Ser
NP_001121173.1:p.Ala308Ser
NP_001121174.1:p.Ala308Ser
NP_001121175.1:p.Ala308Ser
NP_001121176.1:p.Ala308Ser
NP_001121177.1:p.Ala308Ser
NP_001121178.1:p.Ala308Ser
NP_001121179.1:p.Ala308Ser
LRG_575t1:c.922G>T
LRG_575:g.16086G>T
LRG_575p1:p.Ala308Ser
NC_000014.8:g.94845944C>A
NM_000295.4:c.922G>T
NM_001127701.1:c.922G>T
p.Ala308Ser

Protein change:

A308S

Links:

dbSNP: rs141620200

Molecular consequence:

NM_000295.5:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001002235.3:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001002236.3:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127700.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127701.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127702.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127703.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127704.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127705.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127706.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001127707.2:c.922G>T - missense variant - [Sequence Ontology: SO:0001583]

Observations:

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000342565	Eurofins Ntd Llc (ga)	criteria provided, single submitter (EGL Classification Definitions 2015)	Benign (Jun 2, 2016)	germline	clinical testing	Citation Link,
SCV000966516	Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	criteria provided, single submitter (LMM Criteria)	Likely benign (Feb 21, 2013)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000342565

Eurofins Ntd Llc (ga)

criteria provided, single submitter

(EGL Classification Definitions 2015)

Benign
(Jun 2, 2016)

germline

clinical testing

Citation Link,

SCV000966516

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

criteria provided, single submitter

(LMM Criteria)

Likely benign
(Feb 21, 2013)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	not provided	1	1	not provided	not provided	not provided	clinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]

PMID:: 24033266
PMCID:: PMC3995020

Details of each submission

From Eurofins Ntd Llc (ga), SCV000342565.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		1	not provided	not provided	not provided

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000966516.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

Description

Ala308Ser in exon 6 of SERPINA1: This variant is not expected to have clinical s ignificance because it has been identified in 0.4% (33/8600) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs141620200).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	not provided	not provided	not provided	not provided		1	not provided	1	not provided

Last Updated: Jun 20, 2026

ClinVar

Relating variation to medicine